Pharmaceutical Marketing Controversy

973 Words2 Pages

The pharmaceutical industry is known for discovering, developing, producing, and marketing various types of drugs for medications. It is known for bringing in loads of money as shown in 2015 when they made over 86 billion dollars. Looking at that number one surely must ask what their methodology is to be able to have such high values of revenue. That answer lies in a controversy that has been rooted with the pharmaceutical industry since 2002. The year in which the pharmaceutical industry was taking its first steps to facilitate their new marketing practices. This controversy surrounds pharmaceutical marketing and the influence that big pharma imposes on doctors and other health professionals through drug representatives. As Dale Archer, who …show more content…

In the cause of America this practically includes just about everyone on health insurance. There have been many reports on instances in which the diagnosis of the patients would be overly exaggerated so that the doctors could write them prescriptions on the drugs that the pharmaceutical companies incentivize them to do. It’s a practice rife with conflict of interest, leading to over-prescription of medications that may not even be the most appropriate for patients, and it has been the cornerstone of drug marketing for decades” (Archer). Many doctors know how wrong these practices are and some even step up even if it means that they risk being blacklisted by pharmaceutical companies later in the future. As a firsthand witness himself Doctor Archer would describe scenarios in which he along with all the other medical staff know of the wrongdoings. “It was wrong, even when we told ourselves that the freebies would in no way influence our judgment as doctors or dictate what we prescribed. We all took an oath to protect our patients and put their needs first”. One can tell based on the tone and wording of Archer’s dialect that he feels regretful for having to engaged in such practices during his time as a doctor. With insight such as this, Doctor Archer along with other doctors in America know that these marketing practices are not in favor of the …show more content…

Individuals such as John LaMattina who play devil’s advocate. At first glance one would say it is almost impossible to argue in favor of big pharma, however those in favor of them offer factual evidence to support their stance. “The problem is that running a biopharmaceutical company is an expensive and high-risk endeavor. If you cannot generate a very significant profit, you can’t survive” (LaMattina). Having to run a grand business such as a pharmaceutical company is no doubt an easy task and as everyone knows a business’s primary goal is to make money. As pointed out by LaMattina “Clinical trials are typically conducted on drugs developed by labs seeking huge profits. No one stands to make money off aspirin, which has been a generic drug since the Treaty of Versailles in 1919, and which costs less than $6 for a year’s supply”. If a business makes no money, then it cannot sustain itself and it will eventually go bankrupted. As unfortunate as it sounds this also applies to pharmaceutical companies. The companies who say their interest is to produce drugs to help patients but unfortunately follows the same business model as any other

Open Document